Memphis Meats looks to commercialize cell-based meat with $161 million Series B funding

January 24, 2020
Emerging Ecosystems in Agrifood and Health More...
by Harini Venkataraman
Very important

This funding round was led by Temasek, SoftBank Group, and Norwest, with participation from several other investors, including previous ones like Cargill and Tyson Foods. Memphis is the first company in the fast-growing cell-based meat space to raise Series B funding. With about $180 million in funding raised to date, the company hopes to build a pilot production facility and further the commercialization of clean meat products in coming years. Despite this influx of cash, Memphis still has an arduous task in terms of developing cost-efficient serum-free media to achieve cost parity. Nevertheless, cell-based meat will be an important part of the future of proteins, opening up multiple investment and partnership opportunities for clients.

For the original news article, click here .

Further Reading

Microphyt raises $32 million in one of the largest financing deals made within the microalgae sector

News Commentary | July 15, 2019

The round was co‑led by Sofinnova Partners and Bpifrance. This is the largest deal we've seen for a microalgae developer since Lumen Bioscience's $13 million capital infusion in December 2017. As part of the funding, Microphyt will look to accelerate the development and scale‑up of 10 nutritional ... Not part of subscription

Fishing for more funding: Wild Type catches $12.5 million Series A

News Commentary | October 11, 2019

The funding round was led by CRV and included participation from Maven Ventures as well as previous investors Spark Capital and Root Ventures, from Wild Type's $3.5 seed round in 2018. Wild Type will use the funding to develop its cell‑based fish fillet, expand its "chef collaborator community," and... Not part of subscription

Fermentation-derived food proteins gain momentum as Legendairy Foods raises €4 million in funding

News Commentary | December 20, 2019

This investment round was co‑led by M Ventures, the corporate venture arm of Merck, along with Agronomics. This is M Ventures' second investment in the cellular agriculture space, having previously invested in Mosa Meat, a cultured meat startup. Legendairy is using synthetic biology and fermentation... Not part of subscription